3 active warrant series covering 9,682,469 shares (~41.3% potential dilution); nearest expiry 2027-01-31.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| warrant | $0.24 | Jan 31, 2027 123d | 2.3M | OTM | 9.9% | C$559K | Auto |
| warrant | $0.13 | Apr 14, 2029 927d | 7.3M | ITM | 30.9% | C$907K | Filed |
| warrant | $0.13 | Apr 23, 2029 936d | 100K | ITM | 0.4% | C$13K | Auto |
Basis: Current shares & price vs as-filed warrant terms.
3 option grants covering 1,360,000 shares (~5.8% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.30 | Mar 17, 2028 534d | 100K | OTM | 0.4% | C$30K | Auto |
| option | $0.20 | Jun 6, 2028 615d | 363K | OTM | 1.5% | C$73K | Auto |
| option | $0.16 | Dec 10, 2029 1167d | 898K | ITM | 3.8% | C$144K | Auto |
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
23,447,999 shares outstanding, plus 9,682,469 from warrants and 1,360,000 from options — a fully diluted 34,490,468 shares, or ~47.1% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
3 active warrant series covering 9,682,469 shares (~41.3% potential dilution); nearest expiry 2027-01-31.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| warrant | $0.24 | Jan 31, 2027 123d | 2.3M | OTM | 9.9% | C$559K | Auto |
| warrant | $0.13 | Apr 14, 2029 927d | 7.3M | ITM | 30.9% | C$907K | Filed |
| warrant | $0.13 | Apr 23, 2029 936d | 100K | ITM | 0.4% | C$13K | Auto |
Basis: Current shares & price vs as-filed warrant terms.
3 option grants covering 1,360,000 shares (~5.8% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.30 | Mar 17, 2028 534d | 100K | OTM | 0.4% | C$30K | Auto |
| option | $0.20 | Jun 6, 2028 615d | 363K | OTM | 1.5% | C$73K | Auto |
| option | $0.16 | Dec 10, 2029 1167d | 898K | ITM | 3.8% | C$144K | Auto |
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
23,447,999 shares outstanding, plus 9,682,469 from warrants and 1,360,000 from options — a fully diluted 34,490,468 shares, or ~47.1% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
